(9926.HK) ("Akeso" or the "Company") is pleased to announce that the New Drug Application (NDA) of its internally-developed IL-17-targeting monoclonal antibody gumokimab (AK111) has been accepted by ...

The [colorectal cancer field is moving, and thankfully it’s moving quickly,” said Marwan Fakih, gastrointestinal specialist at City of Hope, speaking about initial phase II data from Xilio ...

Anti-SS-A antibodies can be present in QT prolongation arrhythmia, and its presence may suggest that a person is predisposed to ventricular arrhythmias or sudden cardiac death. In some instances, ...

Bispecific antibodies (bispecifics ... strategies such as enhancing immune cell targeting of cancer cells or blocking multiple disease pathways. This dual specificity makes bispecifics effective ...

Legislation that would block hospitals from transfusing blood containing COVID-19 antibodies or “synthetic mRNA” would ...

The Food and Drug Administration (FDA) has approved 2 additional vial sizes of Niktimvo ™ (axatilimab-csfr), 9mg/0.18mL and 22mg/0.44mL, in addition to the 50mg/mL size.

No writing assistance was utilized in the production of this manuscript. Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA).

Legislation that would block hospitals from transfusing blood containing COVID-19 antibodies or “synthetic mRNA” would ...

A breakthrough discovery in enzyme science could revolutionize the treatment of autoimmune disorders and other diseases tied ...